已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

A Systematic Study of Mechanism of Sargentodoxa cuneata and Patrinia scabiosifolia Against Pelvic Inflammatory Disease With Dampness-Heat Stasis Syndrome via Network Pharmacology Approach

小桶 肿瘤坏死因子α 生物 信号转导 癌症研究 药理学 免疫学 细胞生物学 生物化学 基因表达 转录组 基因
作者
Luanqian Hu,Yuqi Chen,Tingting Chen,Dan Huang,Shihua Li,Shuna Cui
出处
期刊:Frontiers in Pharmacology [Frontiers Media SA]
卷期号:11 被引量:12
标识
DOI:10.3389/fphar.2020.582520
摘要

Objective: To investigate the mechanism of Sargentodoxa cuneata (Oliv.) Rehder & E.H.Wilson ( SC ) and Patrinia scabiosifolia ( PS ) against Pelvic Inflammatory Disease with Dampness-Heat Stasis Syndrome via network pharmacological approach and experimental validation. Methods: The active compounds with OB ≥ 30% and DL ≥ 0.18 were obtained from TCMSP database and further confirmed by literature research. The targets of the compounds and disease were acquired from multiple databases, such as GeneCards, CTD and TCMSP database. The intersection targets were identified by Venny software. Cytoscape 3.7.0 was employed to construct the protein-protein interaction (PPI) network and compound-target network. Moreover, GO enrichment and KEGG pathway analysis were analyzed by DAVID database. Finally, CCK-8, Griess assay and a cytometric bead array (CBA) immunoassay were used for experimental validation by detecting the influence of the active compounds on proliferation of macrophage, release of NO and TNF-α after LPS treatment. Results: 9 bioactive compounds were identified from SC and PS . Those compounds corresponded to 134 targets of pelvic inflammatory disease with dampness-heat stasis syndrome. The targets include vascular endothelial growth factor A (VEGFA), von willebrand factor (VWF), interleukin 6 (IL6), tumor necrosis factor (TNF) and nuclear transcription factor 1 (NFκB1). They act on the signaling pathways like advanced glycation end products-receptor of advanced glycation end products (AGE-RAGE), focal adhesion (FA), Toll-like receptor (TLR) and nuclear transcription factor κB (NF-κB). In addition, by in vitro validation, the selected active components of SC and PS such as acacetin, kaempferol, linarin, isovitexin, sinoacutine could significantly inhibit the release of NO induced by LPS, respectively. Moreover, different dose of acacetin, kaempferol, isovitexin and sinoacutine significantly inhibits the TNF-α production. Conclusion: This study provides solid evidence for the anti-inflammatory mechanism of SC and PS against pelvic inflammatory disease with dampness-heat stasis syndrome, which will provide a preliminary evidence and novelty ideas for future research on the two herbs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Leonfun123发布了新的文献求助30
1秒前
3秒前
小蘑菇应助南宫书瑶采纳,获得10
3秒前
5秒前
newplayer完成签到,获得积分10
6秒前
pcr163应助maxj123456采纳,获得60
7秒前
高大的曼文完成签到 ,获得积分10
8秒前
9秒前
CCC完成签到 ,获得积分10
11秒前
11秒前
cxzhao发布了新的文献求助10
12秒前
王博士发布了新的文献求助10
14秒前
15秒前
Lucas应助哈哈悦采纳,获得10
16秒前
17秒前
十三月发布了新的文献求助10
18秒前
科研通AI2S应助cxzhao采纳,获得10
20秒前
完美世界应助无情的琳采纳,获得10
21秒前
30秒前
31秒前
小赵完成签到,获得积分10
31秒前
31秒前
无情的琳完成签到,获得积分20
31秒前
无情的琳发布了新的文献求助10
34秒前
38秒前
CT发布了新的文献求助10
43秒前
研友_ZelDDn发布了新的文献求助10
44秒前
45秒前
隐形的项链完成签到,获得积分10
47秒前
杰king完成签到,获得积分10
49秒前
小巧傥关注了科研通微信公众号
53秒前
56秒前
香蕉觅云应助研友_ZelDDn采纳,获得10
56秒前
kymipu发布了新的文献求助10
57秒前
脑洞疼应助跳跃的聪展采纳,获得10
58秒前
Singularity应助CT采纳,获得20
59秒前
1分钟前
1分钟前
1分钟前
1分钟前
高分求助中
Thermodynamic data for steelmaking 3000
Counseling With Immigrants, Refugees, and Their Families From Social Justice Perspectives pages 800
藍からはじまる蛍光性トリプタンスリン研究 400
Cardiology: Board and Certification Review 400
A History of the Global Economy 350
[Lambert-Eaton syndrome without calcium channel autoantibodies] 340
New Words, New Worlds: Reconceptualising Social and Cultural Geography 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2364747
求助须知:如何正确求助?哪些是违规求助? 2073483
关于积分的说明 5183278
捐赠科研通 1800931
什么是DOI,文献DOI怎么找? 899463
版权声明 557885
科研通“疑难数据库(出版商)”最低求助积分说明 479971